Reta Peptide (Retatrutide) is a synthetic research peptide engineered for advanced metabolic and endocrine studies. Functioning as a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, it has gained significant research interest for its potential in exploring pathways involved in energy balance, glucose metabolism, and body-weight regulation.
With verified peptide purities averaging 99.26 %, this lyophilised compound provides exceptional reproducibility and stability for controlled laboratory-based applications.
✅ 99.26 % Purity – Research Grade
🔬 Triple Receptor Agonist (GLP-1 / GIP / Glucagon Receptors)
🧪 Precision-Tested Lyophilised Peptide
- GLP-1 Receptor: Lowers appetite, slows stomach emptying, and increases fullness.
- GIP Receptor: Enhances insulin release and optimizes fat tissue processing.
- Glucagon (GCG) Receptor: Boosts energy expenditure (calorie burning) and triggers the breakdown of stored liver and body fat
- Profound Weight Loss: Phase 2 and 3 trials demonstrate superior weight reduction compared to older single or dual-agonist therapies like semaglutide or tirzepatide.
- Glycemic Control: Substantially lowers HbA1c levels in individuals with type 2 diabetes.
- Cardiovascular Support: Lowers systolic blood pressure and improves overall blood lipid and cholesterol profiles.
- Liver Health: Promotes significant reductions in liver fat for patients with metabolic dysfunction-associated steatohepatitis (MASH).
- Joint Relief: Alleviates knee pain and inflammation associated with obesity-related osteoarthritis
– Made in United Kingdom (UK)
Disclaimer
While HULK MUSCLES strives to ensure the accuracy of its product images and information, some manufacturing changes to packaging and/or ingredients may be pending update on our site. Although items may occasionally ship with alternate packaging, freshness is always guaranteed. We recommend that you read labels, warnings and directions of all products before use and not rely solely on the information provided by HULK MUSCLES.










